Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 16/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4600613 | 0.91 | PPARG (0.47) | PPARGLMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL4601114 | 0.90 | LMNA (0.47) | PPARGLMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL4601935 | 0.87 | PPARG (0.50) | PPARGLMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL3216016 | 0.85 | TRPM8 (0.42) | PPARGLMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL3211597 | 0.84 | PPARG (0.41) | PPARGLMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL3214134 | 0.83 | PPARG (0.41) | PPARGLMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL3196651 | 0.80 | PPARG (0.59) | PPARGLMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL4602987 | 0.79 | PPARG (0.41) | PPARGLMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL3206552 | 0.78 | PPARG (0.63) | PPARGLMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL3206547 | 0.76 | PPARG (0.62) | PPARGLMNASMN1; SMN2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1912645-A2 | THERAPEUTIC AGENT FOR DIABETES | Takeda Pharmaceutical Company Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007018314-A2 | THERAPEUTIC AGENT FOR DIABETES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-02-15 | — | — | WO | disclosed |